Yan Leyfman, Medical Oncologist, Co-Founder and Executive Director of MedNews Week, shared a post on LinkedIn by MedNews Week, adding:
“Excited to share my Day 2 recap from ASCOBT26 as a 2026 ASCO Voice and ASCO Breakthrough Merit Award recipient.
One message stood out throughout the meeting: the future of oncology will be shaped not only by innovation in AI and precision medicine, but by our commitment to ensuring these advances reach patients everywhere. Grateful for the opportunity to learn from global leaders and share these important conversations.
Thank you to everyone following along. More highlights from Singapore to come!”
Quoting MedNews Week‘s post:
“LIVE from the floor of ASCO Breakthrough 2026 in Singapore
Join Dr. Yan Leyfman, 2026 ASCO Voice and ASCO Breakthrough Merit Award recipient, as he breaks down the biggest highlights from Day 2 of the meeting.
From the rapid integration of artificial intelligence into oncology to innovative strategies for addressing global disparities in cancer care, today’s sessions highlighted how technology, collaboration, and equity are shaping the future of cancer treatment worldwide.
Don’t miss this concise recap of the discoveries and discussions driving the next generation of oncology.”